French company CIS bio international will be the sole distributor of Syncor International’s iodine-125 brachytherapy seeds in Europe, North Africa, and parts of Asia. The Woodland Hills, CA-based Syncor signed on for a 10-year distribution partnership with CIS, a division of Schering.
More than 100,000 new cases of prostate cancer are diagnosed each year in Europe. Radioactive brachytherapy seeds are implanted in the prostate gland to target cancerous tissue.
By AuntMinnie.com staff writers
August 15, 2000
Copyright © 2000 AuntMinnie.com